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Hypertension affects some 25% of adults in the United States and is a major risk factor for stroke, myocardial infarction, and renal insufficiency. 
Epidemiologic studies indicate that between 30% and 
50% of the population variation in diastolic and systolic 
blood pressure (BP) is attributable to genetic factors; spe-
cific genes associated with BP or hypertension have been 
difficult to identify.1 Rare Mendelian forms of hyperten-
sion result in distinctive abnormalities of renal sodium 
handling. Although the specific genetic disorders asso-
ciated with these hypertensions are rare in the general 
hypertensive population, the principle that genetic vari-
ation affecting renal tubular sodium transport and pres-
sure-natriuresis may underlie some fraction of essential 
hypertension suggests the possibility that common alleles 
for other genes involved in renal sodium handling could 
contribute to hypertension. 
One of the most important regulators of sodium bal-
ance is renal dopamine. In normotensive subjects, the 
action of locally released dopamine is responsible for 
more than 50% of incremental sodium excretion during 
states of moderate sodium excess.2 In essential hyperten-
sion the effect of dopamine on renal sodium excretion is 
blunted.3–5 Most studies investigating the role of dopa-
mine receptors in the control of renal sodium excretion 
and BP have focused on the dopamine-1 (D1) receptor, 
and both a D1 receptor gene polymorphism (A-48G) 6 and 
a variant in the G protein-coupled receptor kinase 4 gene 
(GRK4gA142V)7 have been found to be associated with 
hypertension. Others have suggested that diminished 
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Abstract
Background: Dopamine receptor genes are candidates for hypertension susceptibility. Locally released dopamine in-
creases renal sodium excretion, and defective renal dopamine receptor signaling has been shown to play a role 
in hypertension. Dopamine-4 receptors are expressed in juxtaglomerular and cortical collecting cells, where dopa-
mine activation could alter sodium and water metabolism and affect blood pressure (BP). The dopamine-4 recep-
tor (DRD4) gene has a 16 amino acid (48 base pairs [bp]) repeat polymorphism located in exon 3 where a G-protein 
binding area is encoded. The long allele (defined as at least one 7 to 10 repeat) has been associated with the per-
sonality trait Novelty Seeking and with substance abuse, but associations between dopamine-4 receptor polymor-
phisms and BP have not been reported.
Methods: We genotyped 479 female and 385 male subjects of white ethnicity at the DRD4 repeat polymorphism site 
and classified each subject as having either the long or short genotype.
Results: We found associations between the DRD4 long allele and increased systolic BP (P = .031), diastolic BP (P = 
.034), and a history of regular alcohol use (P = .008). Furthermore, for systolic BP (P = .009) and pulse pressure (P 
= .002), we found evidence for an interaction between dopamine-4 receptor alleles and age, indicating that the ef-
fects of dopamine-4 receptor variants on BP increase with age.
Conclusion: In this white population, the long variant of the DRD4 gene is associated with a 3-mm Hg higher systolic 
and 2-mm Hg higher diastolic BP. 
Keywords: blood pressure, dopamine receptor, genetic polymorphism, alcohol, personality, hypertension.
1206
Dopamine-4 ReceptoR polymoRphism anD BlooD pRessuRe 1207
renal dopamine production may play a role.8 Recent evi-
dence points to a potential role for dopamine-2-like (D2) 
receptors in BP regulation.9–11 The site mediating the BP 
effects of both D1 and D2 receptors may well be the kid-
ney, where D1 receptors inhibit renal tubular basolateral 
Na-K ATPase and luminal Na-H antiport and decrease 
tubular sodium reabsorption, whereas activation of D2 
receptors stimulates Na-K ATPase. Thus, either the pro-
posed defect in D1-inhibited or enhancement of D2-stim-
ulated sodium reabsorption could promote hypertension. 
Dopamine-4 (D4) receptors (along with dopamine-
3 receptors) are part of the D2-like family of dopamine 
receptors.11 It has been observed that D4 knockout mice 
show an increase in fear, unconditioned anxiety, and sen-
sitivity to alcohol 12, 13; cardiovascular profiles of these 
mice have not been reported. The most intensively stud-
ied D4 receptor polymorphism is a 48 bp repeat located 
in exon 3 of the D4 receptor gene (DRD4). This variant 
codes for a 16-amino acid sequence located in the third 
intracellular loop of the D4 receptor protein, a region that 
is thought to interact with G-proteins and influence intra-
cellular levels of cAMP.14 The number of repeats at the 
DRD4 site varies from 2 to 10, but in populations of white 
ethnicity the 4 and 7 repeat lengths are the most common. 
Despite much investigation, it is still not clear what func-
tional effect, if any, this polymorphism produces.15, 16
Extensive study has been given to DRD4 in human 
behavioral genetics. The presence of a long allele (7, 8, or 
10 repeat) at the DRD4 site has been strongly associated 
with attention deficit hyperactivity disorder.17 In addi-
tion, there are conflicting, but predominantly negative, 
reports concerning the association of the D4 receptor long 
allele and both increased scores for the personality trait 
Novelty Seeking 18 and alcohol dependence.15, 17, 19 How-
ever, no studies investigating the role of D4 variants in BP 
have been reported. In this study we explored the associ-
ation between DRD4 and BP; we also examined putative 




The present analysis includes 479 female and 385 male 
subjects from 286 families participating in the National 
Heart, Lung, and Blood Institute Family Blood Pres-
sure Program at the site in Tecumseh, MI. Of the sub-
jects, 99% were of non-Hispanic white ethnicity. Family 
eligibility in this study was dependent on the availabil-
ity of a proband between 25 and 40 years old with sys-
tolic BP in the upper 15% of the BP distribution in ear-
lier rounds of examinations and a sibling willing to par-
ticipate.20 Because we used BP as a quantitative pheno-
type in this study, treatment with antihypertensive med-
ications excluded subjects from this analysis. In addition, 
subjects with elevated serum creatinine (> 1.5 mg %), dia-
betes mellitus, pregnancy, or serious medical illness were 
excluded. When available, parents and additional siblings 
of included probands were studied irrespective of BP. All 
participants read and signed an informed consent doc-
ument approved by the University of Michigan Institu-
tional Review Board for Human Subject Research.
Genotyping
The D4 receptor variant was amplified using primers 
D4-42 (5’-AGGACCCTCATGGCCTTG-3’) and D4-3 (5’- 
GCGACTACGTGGTCTACTCG-3’). A PTC 100 thermal 
cycler (MJ Research, Watertown, MA) was used for DNA 
amplification. Amplification reactions were performed in 
a total volume of 20 μL, containing approximately 50 ng 
of genomic template, 1 μmol/L of each primer, 200 μmol/
L dNTP, 2 μL 10X Opti-Prime Buffer #6 (Stratagene, La 
Jolla, CA), and 1 U of Taq polymerase. The polymerase 
chain reaction cycling conditions consisted of an initial 
denaturation for 2 min at 94°C followed by 35 cycles of 
94°C for 1 min, 60°C for 2 min, and 72°C for 2 min, and 
a final extension at 72°C for 4 min. The polymerase chain 
reaction products were electrophoresed on a 2% agarose 
gel and visualized under ultraviolet light using the Gel- 
Star nucleic acid gel stain (BioWhittaker Molecular Appli-
cations, Rockland, ME).
In accordance with previous studies, subjects were 
grouped on the basis of the presence of a long allele (7, 8, 
or 10 repeats).15
Blood Pressure Assessment
Blood pressure measurements were made with a stan-
dardized protocol by a single observer (LG) previously 
trained and certified in BP measurement technique. Two 
manual measurements were obtained for each subject 
with a standard mercury manometer, and the average 
systolic and diastolic BP were used in this study. Pulse 
pressure is the difference between systolic and diastolic 
pressure.
Questionnaire
Personality traits were assessed through the NEO Per-
sonality Inventory (NEO-PI). This inventory, consisting 
of 181 questions, assesses subjects on five global person-
ality domains and breaks down three of these domains 
(Neuroticism, Extraversion, and Agreeableness) into six 
facets each. The NEO-PI is a well established inventory 
constructed through factor analytic strategies and pro-
vides high test-retest reliability and longitudinal stabil-
ity.21 A weighted Novelty Seeking score was calculated 
from NEO-PI domain scores using the formula described 
by Benjamin et al.22
Data necessary to establish diagnoses of alcohol abuse 
and dependence were not collected in this sample. How-
ever, subjects were asked: “Have you ever regularly con-
sumed alcohol in your life?” The presence of association 
between D4 receptor genotypes and subjects’ response to 
this question were also explored. 
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Statistical Analysis 
The presence of association was determined using the 
QTDT Program version 2.1 (available at http://www.
sph.umich.edu/statgen/abecasis/QTDT/ ). QTDT was 
used to fit a variance components model to account for 
familial resemblance because of kinship and linkage. 
However, rather than modeling allelic effects based on 
allelic transmission, we tested the overall additive genetic 
effect of each polymorphism.23, 24 The presence of a statis-
tical interaction between D4 receptor genotypes and age 
for diastolic and systolic BP was determined through a 
general linear model in SPSS 10.0 (SPSS Inc., Chicago, IL). 
Familial resemblance was not considered in testing for 
interactions. A concern in this type of study is the poten-
tial presence of population stratification that could result 
in false association.25 To assess whether the reported 
results were caused by stratification, STRUCTURE, a pro-
gram designed to infer population structure using geno-
types from numerous unlinked markers as genomic con-
trols, was implemented.26
Results
We determined DRD4 genotypes at the D4 receptor repeat 
polymorphism for 864 subjects examined at the Tecum-
seh, MI, site of the National Heart, Lung, and Blood Insti-
tute Family Blood Pressure Program.20 The allele frequen-
cies (adjusted for familial correlation) were consistent 
with previously reported frequencies for white popula-
tions (Table 1).27
In an analysis controlling for familial correlations, we 
found an association between the presence of a D4 recep-
tor long allele and higher systolic (P = .031) and dia-
stolic BP (P = .034) (Table 2) but not pulse pressure (P = 
.179) (Table 2). In addition, there were significant interac-
tions between D4 receptor genotype for age and systolic 
BP (P = .009) and age and pulse pressure (P = .0002). Fig-
ure 1 shows the interaction of age and mean systolic BP. 
For diastolic BP, there was no evidence of an interaction 
between genotype and age (P = .824). 
In this study, subjects with the long allele had a higher 
frequency of self-reported regular alcohol use at some 
point during their lives compared with self-reported 
life-time abstainers (P = .008). We could not distinguish 
between alcohol use and abuse using our available data. 
There was no correlation between reported lifetime his-
tory of alcohol use and systolic BP, diastolic BP, or pulse 
pressure in either male or female subjects in this sample. 
The D4 receptor variants showed no associations with any 
of the five NEO-PI personality traits or with a weighted 
Novelty Seeking personality trait (Table 2).
Weak evidence for clustering into two groups was 
found (P = .02) (B. Thiel and N.J. Schork, unpublished 
observations, 2003). However, there were no significant 
differences in D4 receptor allele frequency, systolic or 
diastolic BP, alcohol use, or any of the personality traits 
between the two clusters. Thus these reported results are 
unlikely to be the product of population stratification.
Discussion
The results of this study indicate that the D4 receptor 
length polymorphism in exon 3 accounts for a small but 
significant proportion of the population variation in both 
systolic and diastolic BP in our sample of individuals of 
white ethnicity. In addition, we find evidence that the 
effect of D4 receptor genotype on systolic BP and pulse 
pressure is strongest in subjects >60 years of age. 
The mechanisms mediating an association between 
the D4 length polymorphism and high BP are unknown, 
as there is limited information available concerning the 
potential role of D4 receptors in cardiovascular or renal 
function. Clozapine, an “atypical” antipsychotic agent 
with a relatively selective D4 affinity, has been reported 
to cause both hypotension and hypertension as well as 
substantial increases in heart rate, perhaps through stim-
ulation of D4 receptors expressed in the heart.28 Experi-
mental studies have identified several renal physiologic 
effects associated with D4 receptor activation. In the cor-
tical collecting tubule, D4 receptors antagonize the effects 
of V2vasopressin receptors and aldosterone, thereby 
decreasing sodium and water reabsorption.29 There is also 
a reported interaction between D4 and angiotensin II type 
1 receptors, which could affect renal sodium reabsorp-
tion.30 Along with proximal and distal tubules, D4 recep-
tors are found prejunctionally in renal nerves that are 
widely distributed in periadventitial tissues of segmen-
tal, arcuate, interlobar, interlobular, afferent, and efferent 
arterioles and the glomerular capillary tuft.31 The expres-
sion of D4 receptors on juxtaglomerular cell suggests a 
possible role in the control of renin release, although a D4 
receptor mutation model in mice does not demonstrate 
alteration of renal function or circulating renin levels.32
The interaction observed between D4 receptor gen-
otypes and age is of interest because systolic and pulse 
pressures rise continuously from middle age onward. It 
seems likely that the effects of genes affecting the level 
of BP differ over time, either because they are active dur-
ing a critical period in the evolution of hypertension or 
because they contribute to age-related target organ effects 
caused by hypertension.33
If D4 receptor genotypes affect renal sodium handling, 
they may contribute to the increasing prevalence of salt 
sensitivity of BP with the aging process.
Table 1. Dopamine receptor 4 allele frequencies
            Allele*                                  Frequency
   2  0.08
   3  0.04
   4  0.68
   5  0.01
   6  <0.01
   7  0.17
   8  <0.01
 10  <0.01
* Data are numbers of repeats.
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In addition to the relationship to BP, we also found an 
association between D4 receptor long alleles and a self-
reported history of regular alcohol use. Most studies that 
have investigated D4 receptor variants and alcohol have 
focused on alcohol dependence or abuse. Although some 
studies have found an association between D4 recep-
tor long alleles and increased incidence or severity of 
these traits, most findings have been negative.15 Given 
our results, it may be fruitful to investigate the role of D4 
receptor in the initiation of alcohol use rather than the 
escalation of alcohol use to the level of abuse and depen-
dence. There is no association in this sample between D4 
receptor and personality traits, a finding consistent with 
the results of two recent meta-analyses.34, 35
In summary, our findings support a role for a com-
mon D4 polymorphism in the control of systolic BP in 
individuals >60 years of age. Investigation of the actions 
of D4 receptors in cardiovascular-renal physiology may 
yield insight into a mechanism of hypertension in human 
beings. 
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